The mechanism of action for tirapazamine involves its activation under hypoxic conditions, which are common in rapidly growing tumors that outpace their blood supply. Once activated, tirapazamine produces free radicals that cause damage to cellular DNA, leading to cell death. This process makes it particularly effective against hypoxic tumor cells, which are often resistant to conventional therapies like radiation and chemotherapy.
